In the United States announced successful test of a test vaccine against the coronavirus in humans. About it it is spoken in the statement of the biotechnology company Moderna.
The first phase of testing began in April. The participation of volunteers aged 18 to 55 years. Positive results of the study affect this phase.
In a statement the company said that after receiving the vaccines the amount of antibodies in volunteers or exceeded the similar indicator in the blood of those who have been exposed to coronavirus or was on the same level.
In the first stage, the drug showed safe, it is transferred without complications. Moderna added that the final stage of clinical trials will begin in July.
Flash coronavirus infection COVID-19 began in late 2019 in China. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.
As of the morning of the 19th of may around the world, the coronavirus has infected 4 805 005 people. Victims COVID-19 318 534 people (+3 thousand per day), recovered 1 787 527 people.
Who believe that the coronavirus would pose a serious threat, until they invent a vaccine. According to the head of the European Agency of medicines Marco Kavaleri, in the best case, the vaccine will be ready next year.
May 15, U.S. President Donald trump said that the coronavirus vaccine may be ready by the end of the year.